Complete remission and relapse rate by signature group stratified by cytogenetic risk groups
| SG group . | Favorable, % CR/relapse . | Intermediate, % CR/relapse . | Unfavorable, % CR/relapse . |
|---|---|---|---|
| 1 | 100/0 | 67/30 | 30/100 |
| 2 | 100/33 | 65/55 | 54/43 |
| 3 | 100/50 | 67/31 | 33/67 |
| 4 | 100/0 | 67/70 | 47/43 |
| 5 | 100/100 | 40/50 | 53/67 |
| 6 | 100/100 | 60/75 | 75/67 |
| 7 | — | 58/29 | 32/83 |
| SG group . | Favorable, % CR/relapse . | Intermediate, % CR/relapse . | Unfavorable, % CR/relapse . |
|---|---|---|---|
| 1 | 100/0 | 67/30 | 30/100 |
| 2 | 100/33 | 65/55 | 54/43 |
| 3 | 100/50 | 67/31 | 33/67 |
| 4 | 100/0 | 67/70 | 47/43 |
| 5 | 100/100 | 40/50 | 53/67 |
| 6 | 100/100 | 60/75 | 75/67 |
| 7 | — | 58/29 | 32/83 |
The 3 major cytogenetic risk groups are unevenly distributed across the seven signature groups. Values are the percentage of patients that have achieved complete remission/the percentage that relapsed.
SG indicates signature group; and —, not applicable.